Patents-Review.com
ClassID:

97053 ⎘

C07K14/70589 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants CD45

Recent Application in this class:
#1
20260115335
2026-04-30

MOLECULES AND THEIR DERIVATIVES DIRECTED AGANIST CD45

 #2
20250213616
2025-07-03

COMPOSITIONS AND METHODS FOR TREATING A REFRACTORY OR RELAPSED CANCER OR A CHRONIC INFECTIOUS DISEASE

 #3
20250179145
2025-06-05

CHIMERIC ANTIGEN RECEPTOR TUMOR INFILTRATING LYMPHOCYTES

 #4
20250144140
2025-05-08

METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

 #5
20250002550
2025-01-02

COMPOUND CHIMERIC ANTIGEN RECEPTOR (CCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF

 #6
20240336903
2024-10-10

Fusion Proteins for Dephosphorylating Proteins that Regulate T Cell Activation through the TCR Signaling Pathway

 #7
20240050567
2024-02-15

MODIFIED IMMUNE EFFECTOR CELL AND USE THEREOF

 #8
20240033292
2024-02-01

Cell

 #9
20240033289
2024-02-01

CELL

 #10
20240009237
2024-01-11

METHOD FOR CRYOPRESERVING ENGINEERED TREGS

 #11
20230398149
2023-12-14

CAR T CELL THERAPY IN PATIENTS WHO HAVE HAD PRIOR ANTI-CANCER ALKYLATOR THERAPY

 #12
20230381232
2023-11-30

METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

 #13
20230293687
2023-09-21

T CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF

 #14
20230265190
2023-08-24

ALLOREACTIVE IMMUNE CELL-DISTANCING DEVICE AND USES THEREOF FOR PROTECTING DONOR-DERIVED CELLS FROM ALLOREJECTION

 #15
20230227525
2023-07-20

CHIMERIC ANTIGEN RECEPTOR FOR TREATMENT OF CANCER

 #16
20230201272
2023-06-29

CELL-BASED THERAPIES AND USES THEREOF

 #17
20230149457
2023-05-18

LONG LIVED T CELLS FOR TREATING HIV INFECTION

 #18
20230079955
2023-03-16

ANTI-MUC1 COMPOSITIONS AND METHODS OF USE

 #19
20230030702
2023-02-02

BLOCKING CHIMERIC ANTIGEN RECEPTORS FOR PREVENTION OF UNDESIRED ACTIVATION OF EFFECTOR AND REGULATORY IMMUNE CELLS

 #20
20220389094
2022-12-08

Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy

 #21
20220387518
2022-12-08

IMMORTALIZED CARDIAC STEM CELLS FOR CARDIAC REPAIR

 #22
20220362295
2022-11-17

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

 #23
20220242948
2022-08-04

ANTI-L1CAM ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME

 #24
20220235366
2022-07-28

Recombinant vector for expressing target protein in plant cell

 #25
20220185860
2022-06-16

CELL SURFACE COUPLING OF NANOPARTICLES

 #26
20210269500
2021-09-02

Cell surface coupling of nanoparticles

 #27
20210244760
2021-08-12

CHIMERIC ANTIGEN RECEPTOR TUMOR INFILTRATING LYMPHOCYTES

 #28
20210187026
2021-06-24

CELL

 #29
20210177898
2021-06-17

Methods and compositions for cellular immunotherapy

 #30
20210154229
2021-05-27

CELL

 #31
20200354737
2020-11-12

Recombinant vector for expressing target protein in plant cell

 #32
20200338219
2020-10-29

MOLECULES AND THEIR DERIVATIVES DIRECTED AGANIST CD45

 #33
20200308541
2020-10-01

Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof

 #34
20200188434
2020-06-18

A CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR)

 #35
20200131239
2020-04-30

Methods and compositions for promoting immune cell function

 #36
20200108142
2020-04-09

CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE

 #37
20200102385
2020-04-02

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

 #38
20200016204
2020-01-16

CELL

 #39
20200016203
2020-01-16

Cell

 #40
20190365806
2019-12-05

IMMUNOLOGICALLY DISCERNIBLE CELL SURFACE VARIANTS FOR USE IN CELL THERAPY

 #41
20190119658
2019-04-25

Modified stem cell memory T cells, methods of making and methods of using same

 #42
20190055309
2019-02-21

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

 #43
20190038672
2019-02-07

Cell

 #44
20180353545
2018-12-13

Methods and compositions for cellular immunotherapy

 #45
20180099994
2018-04-12

Nucleic acid construct

 #46
20170281766
2017-10-05

Chimeric antigen and T cell receptors and methods of use

 #47
20170080104
2017-03-23

Cell surface coupling of nanoparticles

 #48
20160296562
2016-10-13

CELL

 #49
20160289294
2016-10-06

Cell

 #50
20160289293
2016-10-06

Cell

 #51
20110004952
2011-01-06

Method for the separation of cells

 #52
20090280104
2009-11-12

COMPOSITIONS AND METHODS FOR INHIBITING SHIGA TOXIN AND SHIGA-LIKE TOXIN

 #53
20080261831
2008-10-23

Ligands and libraries of ligands